Overexpression of CXCR4 in primary breast tumors is directly correlated to the degree of lymph node metastasis and poor survival rates in breast cancer patients, which suggest that CXCR4 expression could be used as a prognostic marker [41–43]. The gene discussed is CXCR4; the disease is metastatic malignant neoplasm in the lymph nodes.